Related Experiment Videos
The status of hypertriglyceridemia as a risk factor for coronary heart disease
A L Avins1, R J Haber, S B Hulley
1Department of Medicine, University of California, San Francisco.
Insights
Triglycerides remain controversial as an independent risk factor for coronary heart disease. Current evidence does not support treating isolated hypertriglyceridemia due to inconsistent study findings.
Area of Science:
- Cardiology
- Biochemistry
Background:
- The role of triglycerides in coronary heart disease (CHD) risk has been debated for decades.
- Observational studies suggest an association between high triglyceride levels and CHD.
- Clinical trials investigating cholesterol-lowering medications have yielded inconsistent results regarding triglyceride-specific benefits.
Purpose of the Study:
- To review the evidence on triglycerides as an independent risk factor for coronary heart disease.
- To examine observational studies and clinical trials related to triglyceride levels and cardiovascular risk.
- To evaluate the current recommendations for treating isolated hypertriglyceridemia.
Main Methods:
- Systematic review of epidemiological studies.
- Analysis of data from major clinical trials of lipid-lowering therapies.
- Critical appraisal of the association between triglycerides and coronary heart disease events.
Main Results:
- Inconsistent findings between observational studies and clinical trials regarding triglyceride-induced cardiovascular risk.
- Clinical trials of cholesterol-lowering drugs have not consistently demonstrated a reduction in cardiovascular events attributable to triglyceride lowering alone.
- A lack of clear benefit from interventions targeting isolated hypertriglyceridemia.
Conclusions:
- The current evidence does not support treating isolated hypertriglyceridemia as an independent risk factor for coronary heart disease.
- Further research is needed to clarify the precise role of triglycerides in cardiovascular disease pathogenesis and management.
- Clinical decisions regarding triglyceride management should consider the overall lipid profile and patient-specific risk factors.
Abstract:
The three-decade long controversy surrounding the status of triglycerides as an independent risk factor for coronary heart disease is presented. The studies that reported an association and the clinical trials of cholesterol-lowering medications are examined. Because of the inconsistency between the observational findings and the consistently negative clinical trial findings, treatment of isolated hypertriglyceridemia cannot be recommended at present.